ARCHIVES

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

ACCC Planning Session Considers Community Impact

August 31, 1979

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014